H.R. 592 sponsored by Reps. Guthrie (R-KY) and Butterfield (D-NC), will provide access for Medicare beneficiaries in medically underserved communities to covered Medicare Part B services from their pharmacist. Almost 260 members of the U.S. House of Representatives – and nearly 80% of the House Energy & Commerce Committee – co-sponsored this legislation. Pharmacist provider status can better enable pharmacists to help address the opioid epidemic given the unique role they play in our health care system.
The Florida Pharmacy Association issued letters to Representative Gus Bilirakis and Representative Kathy Castor asking for their support to include H.R. 592 on the Committee's April 9th opioid hearing. Both Florida Congressman Bilirakis and Castor are members of the House Energy and Commerce Committee.
Almost 260 members of the US Congress and 80% of the House Energy and Commerce Committee support H.R. 592.
"Pharmacists can also provide opioid management/preventive counseling and/or risk factor reduction interventions at the point of service, which has the potential to substantively reduce abuse." said Michael Jackson, BPharm, Executive Vice President and CEO of the Florida Pharmacy Association. "We can make a huge difference in our state's health care needs particularly in the underserved areas of Florida."
# # #
ABOUT THE FLORIDA PHARMACY ASSOCIATION
The FPA is a state wide professional pharmacy organization united to advance healthcare and pharmacy practice.
128th Annual FPA Meeting and Convention
July 12 - 15, 2018
Hyatt Regency Coconut Point
5001 Coconut Road
Bonita Springs, Florida 34134
Florida Pharmacy Association | 610 North Adams Street, Tallahassee, Florida 32301 (850) 222-2400 | www.pharmview.com
A Member Service of the Florida Pharmacy Association